Changing epidemiology of hepatocellular cancer in the United States: Winning the battle but it is not over yet

Saira Khaderi¹, Fasiha Kanwal^{1

2

3}

Affiliations

¹ Section of Gastroenterology and Hepatology, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.
² Section of Health Services Research, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.
³ VA HSR&D Center for Innovations in Quality, Effectiveness, and Safety (IQuESt), Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas, USA.

Editorial

Saira Khaderi et al. Hepatology. 2022 Sep.

. 2022 Sep;76(3):546-548.

doi: 10.1002/hep.32512. Epub 2022 Apr 22.

Saira Khaderi¹, Fasiha Kanwal^{1

2

3}

¹ Section of Gastroenterology and Hepatology, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.
² Section of Health Services Research, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.
³ VA HSR&D Center for Innovations in Quality, Effectiveness, and Safety (IQuESt), Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas, USA.

No abstract available

Comment on

Declining disease burden of HCC in the United States, 1992-2017: A population-based analysis.
Han J, Wang B, Liu W, Wang S, Chen R, Chen M, Fu Z. Han J, et al. Hepatology. 2022 Sep;76(3):576-588. doi: 10.1002/hep.32355. Epub 2022 Feb 10. Hepatology. 2022. PMID: 35073427
Racial/ethnic disparities in hepatocellular carcinoma incidence and mortality rates in the United States, 1992-2018.
Alvarez CS, Petrick JL, Parisi D, McMahon BJ, Graubard BI, McGlynn KA. Alvarez CS, et al. Hepatology. 2022 Sep;76(3):589-598. doi: 10.1002/hep.32394. Epub 2022 Apr 22. Hepatology. 2022. PMID: 35124828 Free PMC article.

1. Moon AM, Singal AG, Tapper EB. Contemporary epidemiology of chronic liver disease and cirrhosis. Clin Gastroenterol Hepatol. 2020;18(12):2650-66.
1. Petrick JL, Kelly SP, Altekruse SF, McGlynn KA, Rosenberg PS. Future of hepatocellular carcinoma incidence in the United States forecast through 2030. J Clin Oncol. 2016;34(15):1787-94.
1. Petrick JL, Florio AA, Loomba R, McGlynn KA. Have incidence rates of liver cancer peaked in the United States? Cancer. 2020;126(13):3151-5.
1. Han J, Wang B, Liu W, Wang S, Chen R, Chen M, et al. Declining disease burden of hepatocellular carcinoma in the US, 1992-2017: a population-based analysis. Hepatology. 2022;76:576-88.
1. Beste LA, Green P, Berry K, Belperio P, Ioannou GN. Hepatitis C-related hepatocelluar carcinoma in the Veterans Health Administration after introduction of direct-acting antivirals. JAMA. 2020;324(10):1003-5.